<![CDATA[Treatment-Free Remission Implementation and Patient Counseling]]>

TKINeutral

AI Analysis

Summary

Article discusses clinical strategies for implementing treatment-free remission (TFR) in chronic myeloid leukemia patients, including achievement of MR4.5 molecular response, improved adherence, and optimal timing for TKI discontinuation to minimize relapse risk.

Importance:2/10

Sentiment:

0.00

CMLtreatment-free remissionTKIMR4.5patient managementclinical practice

Read the original article

Published by Cancer Network on July 15, 2026 12:00 PM

Read Original